Here are the latest quarterly results of Gammon India. For more details, see the Gammon India financial fact sheet and Gammon India share price and chart.
No. of Mths Qtr. Ending |
3
Sep-15 |
3
Dec-15 |
3
Mar-16 |
3
Jun-16 |
3
Sep-16 |
3
Dec-16 |
3
Mar-17* |
3
Jun-17* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 17,618 | 8,075 | 11,151 | 8,611 | 6,794 | 7,176 | 713 | 293 | |
Other income | Rs m | 817 | 694 | 1,103 | 719 | 765 | 828 | 764 | 625 | |
Turnover | Rs m | 18,435 | 8,769 | 12,254 | 9,330 | 7,560 | 8,003 | 1,477 | 917 | |
Expenses | Rs m | 11,191 | 7,845 | 9,265 | 8,589 | 6,242 | 6,144 | 1,643 | 791 | |
Gross profit | Rs m | 6,427 | 231 | 1,885 | 22 | 553 | 1,032 | 14,657 | 4,372 | |
Depreciation | Rs m | 685 | 352 | 307 | 292 | 293 | 293 | 30 | 26 | |
Interest | Rs m | 1,740 | 1,798 | 1,689 | 1,422 | 1,829 | 1,800 | 1,299 | 1,355 | |
Profit before tax | Rs m | 4,818 | -1,226 | 993 | -973 | -804 | -233 | 14,092 | 3,615 | |
Tax | Rs m | -224 | -14 | 459 | -67 | -84 | -28 | 29 | 0 | |
Profit after tax | Rs m | 5,042 | -1,212 | 534 | -906 | -719 | -205 | 14,063 | 3,615 | |
Gross profit margin | % | 36.5 | 2.9 | 16.9 | 0.3 | 8.1 | 14.4 | 2,056.3 | 1,494.6 | |
Effective tax rate | % | -4.6 | 1.1 | 46.2 | 6.9 | 10.5 | 12.0 | 0.2 | 0.0 | |
Net profit margin | % | 28.6 | -15.0 | 4.8 | -10.5 | -10.6 | -2.9 | 1,972.9 | 1,235.8 | |
Diluted EPS | Rs | 36.9 | -8.9 | 3.9 | -6.6 | -5.3 | -1.5 | 103.0 | 26.5 | |
Diluted EPS (TTM) | Rs | 6.2 | 9.3 | 18.2 | 25.3 | -16.9 | -9.5 | 89.6 | 122.7 | |
![]() |
More Construction Company Quarterly Results: IVRCL HCC ASHOKA BUILDCON MAHINDRA LIFESPACE HDIL
Compare GAMMON INDIA With: IVRCL HCC ASHOKA BUILDCON MAHINDRA LIFESPACE HDIL
Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 34 points, up 0.1% at 48,844 levels.
Should you apply for the IPO of Mindspace Business Parks REIT?
Government's push to affordable housing will revive the real estate sector.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More